PDCD1 and pneumonitis: Seven studies reported serious pneumonitis and integrated data showed that PD-1 or PD-L1 inhibitors combined with chemotherapy increased the risk of pneumonitis (OR = 2.52, 95% CI: 1.02–6.26), as is shown in Figure 3.